| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.099 | 0.008 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.008 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |